banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Paritaprevir (ABT-450) CAS 1216941-48-8

Paritaprevir (ABT-450) CAS 1216941-48-8

CAS Nr .: 1216941-48-8
Cov roj formula: C40H43N7O7S
Molecular Luj: 765.87700
EINECS NO: NA
MDL NO: NA

Txhawb tshuaj

Product Description:

Khoom npe: Paritaprevir (ABT-450) CAS NO: 1216941-48-8

Synonyms:

(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1, 2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide;

Veruprevir anhydrous;

Tshuaj& Lub cev muaj zog:

Cov tsos mob: Khoom lossis kua

Kev Ntsuas: ≥99.0%

Ceev: 1.45 ± 0.1 g / cm3 (Predicted)

Paritaprevir (ABT-450) yog ib qho muaj zog uas tsis yog cov qauv protein 3/4A (NS3/4A) protease inhibitor nrog EC50s ntawm 1 thiab 0.21 nM tiv thaiv HCV 1a thiab 1b, raws li.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom raws li patent muaj rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.


Cim npe nrov: paritaprevir (abt-450) CAS 1216941-48-8, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

Xa kev nug